| 摘要 |
PCT No. PCT/EP94/02650 Sec. 371 Date Jun. 27, 1996 Sec. 102(e) Date Jun. 27, 1996 PCT Filed Aug. 10, 1994 PCT Pub. No. WO95/05829 PCT Pub. Date Mar. 2, 1995A therapeutic system for topically administering active substances for the treatment of skin diseases involving severe cell proliferation is characterized in that the active substance is a pharmaceutically acceptable derivate of vitamin D3, with the exception of such derivates as serve to regulate the calcium metabolism.
|
